Ticker
ABMD

Price
-
Stock movement up
+- (%)
Company name
ABIOMED Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Marknadsvärde
17.18B
Ent-värde
17.16B
Pris/omsättning
16.00
Pris/bok
11.16
Direktavkastning
-
Utdelningens tillväxt
-
Tillväxt år
-
FCF-utbetalning
-
Efterföljande P/E
64.40
Fremtidig P/E
60.77
PEG
-
EPS-tillväxt
-
1 års avkastning
8.18%
3 års avkastning
30.28%
5 års avkastning
14.86%
10 års avkastning
39.53%
Senast uppdaterad: 2023-03-10
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
22 december 2022

iO Charts is a Seeking Alpha partner

JNJ's agreed acquisition of ABMD at $380 per share came as a surprise to many healthcare focused investors. Click here to read our most recent analysis.
21 december 2022

iO Charts is a Seeking Alpha partner

UTDELNING

ABMD Betalar inte utdelning
Loading...
AD

UTVÄRDERING

Värderingsvillkor

Loading...
Data om värderingsgrad
Efterföljande P/E64.40
Pris till OCF68.45
Pris till FCF112.19
Pris till EBITDA46.29
EV i förhållande till EBITDA46.22

Värdering (Försäljning/Bokfört värde)

Loading...
Värderingsdata (försäljning/bokfört värde)
Pris till omsättning16.00
Pris till eget kapital11.16
EV i förhållande till försäljning15.97
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
19 december 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
8 december 2022

iO Charts is a Seeking Alpha partner

EKONOMI

Per aktie

Loading...
Data per aktie
Nuvarande aktiemängd45.09M
EPS (TTM)5.84
FCF per aktie (TTM)3.35

Resultaträkning

Loading...
Uppgifter om resultaträkningen
Intäkter (TTM)1.07B
Bruttovinst (TTM)873.51M
Rörelseintäkter (TTM)253.61M
Nettoresultat (TTM)266.76M
EPS (TTM)5.84
EPS (1 år framåt)6.27

Marginaler

Loading...
Marginer-data
Bruttomarginal (TTM)81.32%
Rörelsemarginal (TTM)23.61%
Vinstmarginal (TTM)24.84%

Balans

Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om balansräkningen
Kontanter182.34M
Nettofordringar94.47M
Summa omsättningstillgångar1.06B
Goodwill72.96M
Immateriella tillgångar50.13M
Materiella anläggningstillgångar0.00
Summa tillgångar1.70B
Leverantörsskulder35.07M
Kortfristig/kortfristig långfristig skuld0.00
Summa kortfristiga skulder134.06M
Summa skulder156.76M
Eget kapital1.54B
Materiella anläggningstillgångar netto1.43B

Kassaflöde

Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om kassaflöde
Kassaflöde från den löpande verksamheten (TTM)250.98M
Investeringar (TTM)33.76M
Fritt kassaflöde (TTM)153.14M
Utbetald utdelning (TTM)0.00

Finansiella intäkter

Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om finansiella intäkter
Avkastning på eget kapital17.32%
Avkastning på tillgångar15.72%
Avkastning på investerat kapital17.32%
Kontantavkastning på investerat kapital9.95%
Loading...
AD

INFORMATION OM AKTIER

Potential på nackdelen

Loading...
Negativa potentiella data
ABMDS&P500
Nuvarande prisfall från toppnotering-15.28%-19.84%
Högsta prisfallet-94.31%-56.47%
Datum för högsta fall9 Oct 20029 Mar 2009
Genomsnittligt fall från topp-47.58%-11.49%
Genomsnittlig tid till ny topp46 days13 days
Maxtid till ny topp3756 days1805 days
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1 november 2022

iO Charts is a Seeking Alpha partner

Abiomed, Inc. (NASDAQ:NASDAQ:ABMD) Q2 2023 Earnings Conference Call November 1, 2022 8:00 AM ETCompany ParticipantsJessica Moore - Vice President of...
1 november 2022

iO Charts is a Seeking Alpha partner

UPPLYSNINGAR OM FÖRETAG
ABMD (ABIOMED Inc) company logo
Marknadsvärde
17.18B
Kategori av marknadsvärde
Large-cap
Beskrivning: __________
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.
Anställda
2003
Investerarrelationer
-
SEC-inlämningar
Verkställande direktör
Michael R. Minogue
Land
USA
By
Danvers
Typ av aktie
Common stock
CCC-status
-
Utdelningsfrekvens
-
EVENEMANG OCH PRESENTATIONER
EvenemangPresentationer
Loading...
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1 november 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1 november 2022

iO Charts is a Seeking Alpha partner

FÖRSTÅ VERKSAMHETEN
Loading...
NYHETER OM FÖRETAGET
Seeking AlphaPressmeddelanden
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1 november 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1 november 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
31 oktober 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
20 oktober 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
17 oktober 2022
Abiomed is a compelling growth story in the medical technology space. See why we believe ABMD’s long-term investors can buy stock around current price.
28 september 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
16 september 2022
Abiomed, Inc. (NASDAQ:NASDAQ:ABMD) Q1 2023 Results Conference Call August 4, 2022 8:00 AM ETCompany ParticipantsNicole Nath - Manager, Investor...
4 augusti 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
4 augusti 2022
Abiomed reported robust earnings yesterday with double-digit growth from top-bottom. See why we remain unchanged on our previous rating of buy on ABMD stock.
4 augusti 2022
iO Charts is a Seeking Alpha partnerNästa sida